In the newly fertilized C. elegans embryo, the meiotic and mitotic spindles form in the same cytoplasm.
mei-1/mei-2 (katanin) form a microtubule-severing complex required for the meiotic spindle and must be inhibited post-meiotically by
mel-26 for mitotic spindle formation(1,2). MEI-1/MEI-2 localize to the meiotic chromatin, spindles and spindle poles of the meiotic spindle(3). In
mel-26(lf) the mitotic spindle is small and mis-oriented due to ectopic MEI-1/MEI-2 mitotic microtubule severing, indicating that MEL-26 inhibits MEI-1/MEI-2 after meiosis(1).
mel-26 has a mutant phenotype similar to
rfl-1(4).
rfl-1 is a component of the E1 in the
ned-8 ubiquitin-like (UBL) pathway, which activates the ubiquitin (UBQ) protein degradation pathway. These two mutants are also similar in their genetic interactions with
mei-1 (2,4), suggesting that MEL-26 may inhibit MEI-1 by targeting it for degradation. MEI-1 contains a PEST motif, commonly found among proteins subject to UBQ-mediated degradation. In a
mei-1(gf) allele, this motif is abolished and the protein refractory to MEL-26 regulation.Yeast two-hybrid interactions between MEL-26, MEI-1 and MEI-2 reinforce the genetic conclusions and indicate the interaction between MEL-26 and MEI-1 is direct. MEI-1 interacts with itself, MEL-26 and MEI-2. However MEI-1(gf) does not interact with MEL-26 but still binds MEI-1(+) and MEI-2. This suggests that MEI-1(gf) forms a microtubule-severing complex that cannot be inhibited by MEL-26.We are interested in determining how MEL-26 inhibits MEI-1 and how MEL-26 expression is regulated. MEL-26 displays both cytoplasmic and membrane localization in the early embryo that appears after meiosis is completed, thus MEL-26 cannot inhibit MEI-1 during meiosis. Preliminary results indicate MEL-26 expression at the 1-4 cell stage is disrupted in a UBL pathway mutant, suggesting MEL-26 itself may be regulated by degradation(5). We are characterizing the temporal expression pattern of MEL-26 and looking for changes in MEL-26 expression in UBQ and UBL pathway mutants.(1)Srayko, et al, 2000. Genes Dev.14:1072-1084 (2)Dow and Mains,1998. Genetics 150:119-128 (3)Clark-Maguire and Mains,1994. JCB 126(1)199-209 (4)Kurz, et al, 2002. Science 295:1294-1298 (5)Galan and Peter,1999. PNAS 96:9124-9129